$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Xerostomia
구강건조증 원문보기

臨床耳鼻咽喉科 = Journal of clinical otolaryngology, v.31 no.1, 2020년, pp.11 - 17  

Kwon, Hyun-Keun ,  Lee, Jin-Choon ,  Lee, Byung-Joo

초록이 없습니다.

참고문헌 (51)

  1. 10.4103/2141-9248.139284 Mortazavi H, Baharvand M, Movahhedian A, Mohammadi M, Khodadoustan A. Xerostomia due to systemic disease: a review of 20 conditions and mechanisms. Ann Med Health Sci Res 2014;4(4):503-10. 10.4103/2141-9248.139284 25221694 PMC4160670 

  2. 10.2147/TCRM.S76282 Villa A, Connell CL, Abati S. Diagnosis and management of xerostomia and hyposalivation. Ther Clin Risk Manag 2015;11:45-51. 10.2147/TCRM.S76282 25653532 PMC4278738 

  3. 10.1016/j.jpor.2014.11.001 Han P, Suarez-Durall P, Mulligan R. Dry mouth: a critical topic for older adult patients. J Prosthodont Res 2015;59 (1):6-19. 10.1016/j.jpor.2014.11.001 25498205 

  4. 10.5005/jp-journals-10024-1034 Mirzaii-Dizgah I, Agha-Hosseini F. Unstimulated whole saliva parathyroid hormone in postmenopausal women with xerostomia. J Contemp Dent Pract 2011;12(3):196-9. 10.5005/jp-journals-10024-1034 22186816 

  5. 10.1016/j.clindermatol.2017.06.010 Millsop JW, Wang EA, Fazel N. Etiology, evaluation, and management of xerostomia. Clin Dermatol 2017;35(5):468-76. 10.1016/j.clindermatol.2017.06.010 28916028 

  6. 10.17219/acem/29375 Tanasiewicz M, Hildebrandt T, Obersztyn I. Xerostomia of various etiologies: a review of the literature. Adv Clin Exp Med 2016;25(1):199-206. 10.17219/acem/29375 26935515 

  7. 10.1007/s00784-010-0382-1 van der Putten GJ, Brand HS, Schols JM, de Baat C. The diagnostic suitability of a xerostomia questionnaire and the association between xerostomia, hyposalivation and medication use in a group of nursing home residents. Clin Oral Investig 2011;15(2):185-92. 10.1007/s00784-010-0382-1 20165967 PMC3056013 

  8. 10.1034/j.1601-0825.2002.02851.x Pedersen AM, Bardow A, Jensen SB, Nauntofte B. Saliva and gastrointestinal functions of taste, mastication, swallowing and digestion. Oral Dis 2002;8(3):117-29. 10.1034/j.1601-0825.2002.02851.x 12108756 

  9. 10.14219/jada.archive.2011.0269 Villa A, Polimeni A, Strohmenger L, Cicciu D, Gherlone E, Abati S. Dental patients’ self-reports of xerostomia and associated risk factors. J Am Dent Assoc 2011;142(7): 811-6. 10.14219/jada.archive.2011.0269 21719803 

  10. 10.1007/s002280050298 Bagheri H, Schmitt L, Berlan M, Montastruc JL. A comparative study of the effects of yohimbine and anetholtrithione on salivary secretion in depressed patients treated with psychotropic drugs. Eur J Clin Pharmacol 1997;52(5):339-42. 10.1007/s002280050298 9272401 

  11. 10.1046/j.1464-410X.1997.00365.x Hooper P, Tincello DG, Richmond DH. The use of salivary stimulant pastilles to improve compliance in women taking oxybutynin hydrochloride for detrusor instability: a pilot study. Br J Urol 1997;80(3):414-6. 10.1046/j.1464-410X.1997.00365.x 9313659 

  12. 10.1177/154405910408300508 Gotrick B, Akerman S, Ericson D, Torstenson R, Tobin G. Oral pilocarpine for treatment of opioid-induced oral dryness in healthy adults. J Dent Res 2004;83(5):393-7. 10.1177/154405910408300508 15111631 

  13. 10.1176/appi.ajp.162.5.1023 Masters KJ. Pilocarpine treatment of xerostomia induced by psychoactive medications. Am J Psychiatry 2005;162(5):1023. 10.1176/appi.ajp.162.5.1023 15863819 

  14. 10.4317/medoral.18206 Gomez-Moreno G, Guardia J, Aguilar-Salvatierra A, Cabrera-Ayala M, Mate-Sanchez de-Val JE, Calvo-Guirado JL. Effectiveness of malic acid 1% in patients with xerostomia induced by antihypertensive drugs. Med Oral Patol Oral Cir Bucal 2013;18(1):e49-55. 10.4317/medoral.18206 22926481 PMC3548619 

  15. 10.2147/TCRM.S70652 Pinna R, Campus G, Cumbo E, Mura I, Milia E. Xerostomia induced by radiotherapy: an overview of the physiopathology, clinical evidence, and management of the oral damage. Ther Clin Risk Manag 2015;11:171-88. 10.2147/TCRM.S70652 25691810 PMC4325830 

  16. 10.2307/3576264 Mossman KL. Quantitative radiation dose-response relationships for normal tissues in man. II. Response of the salivary glands during radiotherapy. Radiat Res 1983;95(2):392-8. 10.2307/3576264 6611856 

  17. 10.3181/00379727-157-39988 Shannon IL, Trodahl JN, Starcke EN. Radiosensitivity of the human parotid gland. Proc Soc Exp Biol Med 1978; 157(1):50-3. 10.3181/00379727-157-39988 622373 

  18. 10.1016/0167-8140(94)90006-X Leslie MD, Dische S. The early changes in salivary gland function during and after radiotherapy given for head and neck cancer. Radiother Oncol 1994;30(1):26-32. 10.1016/0167-8140(94)90006-X 

  19. 10.1016/S0360-3016(00)01441-3 Chao KS, Deasy JO, Markman J, Haynie J, Perez CA, Purdy JA, et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 2001;49(4):907-16. 10.1016/S0360-3016(00)01441-3 

  20. 10.1177/10454411930040030301 Valdez IH, Fox PC. Diagnosis and management of salivary dysfunction. Crit Rev Oral Biol Med 1993;4(3-4): 271-7. 10.1177/10454411930040030301 8373984 

  21. Thomson WM, Chalmers JM, Spencer AJ, Williams SM. The xerostomia inventory: a multi-item approach to measuring dry mouth. Community Dent Health 1999;16(1): 12-7. 

  22. 10.1111/j.1601-0825.2010.01715.x Osailan S, Pramanik R, Shirodaria S, Challacombe SJ, Proctor GB. Investigating the relationship between hyposalivation and mucosal wetness. Oral Diseases 2011;17(1):109-14. 10.1111/j.1601-0825.2010.01715.x 21029258 

  23. 10.14219/jada.archive.2005.0137 Chen A, Wai Y, Lee L, Lake S, Woo SB. Using the modified Schirmer test to measure mouth dryness: a preliminary study. J Am Dent Assoc 2005;136(2):164-70; quiz 229-30. 10.14219/jada.archive.2005.0137 15782519 

  24. 10.1111/j.1749-6632.1993.tb18343.x Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci 1993;694:72-7. 10.1111/j.1749-6632.1993.tb18343.x 8215087 

  25. 10.1177/00220345920710070301 Navazesh M, Christensen C, Brightman V. Clinical criteria for the diagnosis of salivary gland hypofunction. J Dent Res 1992;71(7):1363-9. 10.1177/00220345920710070301 1629451 

  26. Kruszka P, O’Brian RJ. Diagnosis and management of Sjogren syndrome. Am Fam Physician 2009;79(6):465-70. 

  27. 10.1001/archinte.147.7.1333 Sreebny LM, Valdini A. Xerostomia. A neglected symptom. Arch Intern Med 1987;147(7):1333-7. 10.1001/archinte.1987.00370070145022 

  28. 10.1016/j.oraloncology.2008.11.014 Teymoortash A, Muller F, Juricko J, Bieker M, Mandic R, Librizzi D, et al. Botulinum toxin prevents radiotherapy-induced salivary gland damage. Oral Oncol 2009;45(8): 737-9. 10.1016/j.oraloncology.2008.11.014 19213593 

  29. 10.1016/j.ijrobp.2010.03.035 Limesand KH, Avila JL, Victory K, Chang HH, Shin YJ, Grundmann O, et al. Insulin-like growth factor-1 preserves salivary gland function after fractionated radiation. Int J Radiat Oncol Biol Phys 2010;78(2):579-86. 10.1016/j.ijrobp.2010.03.035 20638195 PMC2939244 

  30. 10.1634/stemcells.2007-1034 Lombaert IM, Brunsting JF, Wierenga PK, Kampinga HH, de Haan G, Coppes RP. Keratinocyte growth factor prevents radiation damage to salivary glands by expansion of the stem/progenitor pool. Stem Cells 2008;26(10):2595-601. 10.1634/stemcells.2007-1034 18669914 

  31. 10.1038/ncomms3498 Ogawa M, Oshima M, Imamura A, Sekine Y, Ishida K, Yamashita K, et al. Functional salivary gland regeneration by transplantation of a bioengineered organ germ. Nat Commun 2013;4:2498. 10.1038/ncomms3498 24084982 PMC3806330 

  32. 10.1158/1078-0432.CCR-03-0194 Vitolo JM, Cotrim AP, Sowers AL, Russo A, Wellner RB, Pillemer SR, et al. The stable nitroxide tempol facilitates salivary gland protection during head and neck irradiation in a mouse model. Clin Cancer Res 2004;10(5): 1807-12. 10.1158/1078-0432.CCR-03-0194 15014035 

  33. 10.2146/ajhp120467 Radvansky LJ, Pace MB, Siddiqui A. Prevention and management of radiation-induced dermatitis, mucositis, and xerostomia. Am J Health Syst Pharm 2013;70(12): 1025-32. 10.2146/ajhp120467 23719879 

  34. 10.1111/j.1601-0825.2006.01252.x Aframian DJ, Helcer M, Livni D, Robinson SD, Markitziu A, Nadler C. Pilocarpine treatment in a mixed cohort of xerostomic patients. Oral Diseases 2007;13(1):88-92. 10.1111/j.1601-0825.2006.01252.x 17241436 

  35. 10.1007/s00520-002-0409-5 Nieuw Amerongen AV, Veerman EC. Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. Support Care Cancer 2003;11(4): 226-31. 10.1007/s00520-002-0409-5 12673460 

  36. 10.1016/j.archoralbio.2014.10.004 Saleh J, Figueiredo MA, Cherubini K, Salum FG. Salivary hypofunction: an update on aetiology, diagnosis and therapeutics. Arch Oral Biol 2015;60(2):242-55. 10.1016/j.archoralbio.2014.10.004 25463902 

  37. 10.1016/j.oraloncology.2006.01.013 Jham BC, Teixeira IV, Aboud CG, Carvalho AL, Coelho Mde M, Freire AR. A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer. Oral Oncol 2007;43(2):137-42. 10.1016/j.oraloncology.2006.01.013 16798061 

  38. 10.1016/S0002-9629(15)40606-8 Hamada T, Nakane T, Kimura T, Arisawa K, Yoneda K, Yamamoto T, et al. Treatment of xerostomia with the bile secretion-stimulating drug anethole trithione: a clinical trial. Am J Med Sci 1999;318(3):146-51. 10.1097/00000441-199909000-00009 10487404 

  39. 10.3109/00016359109005919 Olsson H, Spak CJ, Axell T. The effect of a chewing gum on salivary secretion, oral mucosal friction, and the feeling of dry mouth in xerostomic patients. Acta Odontol Scand 1991;49(5):273-9. 10.3109/00016359109005919 1803848 

  40. 10.1136/ard.58.8.465 van der Reijden WA, Vissink A, Veerman EC, Amerongen AV. Treatment of oral dryness related complaints (xerostomia) in Sjogren’s syndrome. Ann Rheum Dis 1999; 58(8):465-74. 10.1136/ard.58.8.465 10419864 PMC1752926 

  41. 10.1002/da.22017 Gomez-Moreno G, Aguilar-Salvatierra A, Guardia J, Uribe-Marioni A, Cabrera-Ayala M, Delgado-Ruiz RA, et al. The efficacy of a topical sialogogue spray containing 1% malic acid in patients with antidepressant-induced dry mouth: a double-blind, randomized clinical trial. Depress Anxiety 2013;30(2):137-42. 10.1002/da.22017 23124914 

  42. 10.2165/00002512-200724110-00007 Mouly S, Salom M, Tillet Y, Coudert AC, Oberli F, Preshaw PM, et al. Management of xerostomia in older patients: a randomised controlled trial evaluating the efficacy of a new oral lubricant solution. Drugs Aging 2007;24(11): 957-65. 10.2165/00002512-200724110-00007 17953462 

  43. 10.1111/j.1365-2842.2006.01718.x Ship JA, McCutcheon JA, Spivakovsky S, Kerr AR. Safety and effectiveness of topical dry mouth products containing olive oil, betaine, and xylitol in reducing xerostomia for polypharmacy-induced dry mouth. J Oral Rehabil 2007;34(10):724-32. 10.1111/j.1365-2842.2006.01718.x 17824884 

  44. 10.1177/026921639701100307 Sweeney MP, Bagg J, Baxter WP, Aitchison TC. Clinical trial of a mucin-containing oral spray for treatment of xerostomia in hospice patients. Palliat Med 1997;11(3): 225-32. 10.1177/026921639701100307 9205656 

  45. 10.1016/j.oooo.2012.01.012 Alajbeg I, Falcao DP, Tran SD, Martin-Granizo R, Lafaurie GI, Matranga D, et al. Intraoral electrostimulator for xerostomia relief: a long-term, multicenter, open-label, uncontrolled, clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol 2012;113(6):773-81. 10.1016/j.oooo.2012.01.012 22668705 

  46. 10.1136/aim.2010.002733 O’Sullivan EM, Higginson IJ. Clinical effectiveness and safety of acupuncture in the treatment of irradiation-induced xerostomia in patients with head and neck cancer: a systematic review. Acupunct Med 2010;28(4):191-9. 10.1136/aim.2010.002733 21062848 

  47. 10.1016/j.ijrobp.2008.11.056 Teguh DN, Levendag PC, Noever I, Voet P, van der Est H, van Rooij P, et al. Early hyperbaric oxygen therapy for reducing radiotherapy side effects: early results of a randomized trial in oropharyngeal and nasopharyngeal cancer. Int J Radiat Oncol Biol Phys 2009;75(3):711-6. 10.1016/j.ijrobp.2008.11.056 19386439 

  48. 10.1371/journal.pone.0095968 Gu J, Zhu S, Li X, Wu H, Li Y, Hua F. Effect of amifostine in head and neck cancer patients treated with radio-therapy: a systematic review and meta-analysis based on randomized controlled trials. PLoS One 2014;9(5):e95968. 10.1371/journal.pone.0095968 24788761 PMC4008569 

  49. 10.1371/journal.pone.0141862 An HY, Shin HS, Choi JS, Kim HJ, Lim JY, Kim YM. Adipose mesenchymal stem cell secretome modulated in hypoxia for remodeling of radiation-induced salivary gland damage. PLoS One 2015;10(11):e0141862. 10.1371/journal.pone.0141862 26529411 PMC4631328 

  50. 10.1371/journal.pone.0071167 Lim JY, Ra JC, Shin IS, Jang YH, An HY, Choi JS, et al. Systemic transplantation of human adipose tissue-derived mesenchymal stem cells for the regeneration of irradiation-induced salivary gland damage. PLoS One 2013;8(8):e71167. 10.1371/journal.pone.0071167 23951100 PMC3739795 

  51. 10.2217/fon.13.79 Noaparast Z, Hosseinimehr SJ. Radioprotective agents for the prevention of side effects induced by radioio-dine-131 therapy. Future Oncol 2013;9(8):1145-59. 10.2217/fon.13.79 23902246 

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로